Literature DB >> 10823182

Yeasts and fluconazole susceptibility in the Philippines.

G S Bulmer1, M L Marquez, L Co-Barcelona, R A Fromtling.   

Abstract

Identification and fluconazole susceptibility of 579 yeasts isolated from patients in 16 medical centers throughout the Philippines in 1997-98 is reported. Speciation revealed the following distribution of yeasts (with percent occurrence): Candida albicans (49.6%); C. parapsilosis (17.2%); C. tropicalis (14.9%); C. glabrata (6.2%); C. pelliculosa (4.3%); C. krusei (2.4%); C. guilliermondii (1.9%); Trichosporon cutaneum (1.7%); Cryptococcus neoformans (0.9%); Candida famata (0.5%); C. lusitaniae (0.2%) and Saccharomyces cerevisiae (0.2%). Using an agar disk diffusion assay for fluconazole susceptibility it was determined that 94% of the isolates were susceptible, 5% dose-dependent susceptible and only 1% resistant. All isolates of C. albicans were susceptible (one being dose dependent sensitive) to fluconazole. The only yeasts resistant to fluconazole were: C. guillermondii (1 isolate), C. glabrata (3 isolates) and C. parapsilosis (1 isolate).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10823182     DOI: 10.1023/a:1007025212469

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  19 in total

Review 1.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

2.  Value of antifungal prophylaxis with antifungal drugs against oropharyngeal candidiasis in cancer patients.

Authors:  F Meunier; M Paesmans; P Autier
Journal:  Eur J Cancer B Oral Oncol       Date:  1994-05

3.  Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.

Authors:  F S Nolte; T Parkinson; D J Falconer; S Dix; J Williams; C Gilmore; R Geller; J R Wingard
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

4.  Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation.

Authors:  K A Marr; T C White; J A van Burik; R A Bowden
Journal:  Clin Infect Dis       Date:  1997-10       Impact factor: 9.079

5.  The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team.

Authors:  P H Chandrasekar; C M Gatny
Journal:  J Antimicrob Chemother       Date:  1994-02       Impact factor: 5.790

6.  Mortality of hospitalized patients with Candida endophthalmitis.

Authors:  A V Menezes; D A Sigesmund; W A Demajo; R G Devenyi
Journal:  Arch Intern Med       Date:  1994-09-26

7.  Fluconazole-resistant Candida in AIDS patients. Report of two cases.

Authors:  G S Heinic; D A Stevens; D Greenspan; L A MacPhail; C L Dodd; S Stringari; W M Strull; H Hollander
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1993-12

8.  Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.

Authors:  M Ruhnke; A Eigler; I Tennagen; B Geiseler; E Engelmann; M Trautmann
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

Review 9.  Prophylaxis of opportunistic infections in persons with HIV infection.

Authors:  B F Stearn; M A Polis
Journal:  Cleve Clin J Med       Date:  1994 May-Jun       Impact factor: 2.321

Review 10.  Resistance of yeasts to azole-derivative antifungals.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  1993-04       Impact factor: 5.790

View more
  3 in total

1.  Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

Review 2.  Two cases of vaginitis caused by itraconazole-resistant Saccharomyces cerevisiae and a review of recently published studies.

Authors:  Vincenzo Savini; Chiara Catavitello; Assunta Manna; Marzia Talia; Fabio Febbo; Andrea Balbinot; Francesco D'Antonio; Giovanni Di Bonaventura; Claudio Celentano; Marco Liberati; Raffaele Piccolomini; Domenico D'Antonio
Journal:  Mycopathologia       Date:  2008-04-29       Impact factor: 2.574

3.  Saccharomyces cerevisiae: population divergence and resistance to oxidative stress in clinical, domesticated and wild isolates.

Authors:  Stephanie Diezmann; Fred S Dietrich
Journal:  PLoS One       Date:  2009-04-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.